Pneumonia caused by the opportunistic pathogen Pneumocystis carinii is a primary cause of mortality in patients with acquired immunodeficiency syndrome, and in other immunocompromised hosts. The long range objective of the proposal is to determine the basis of acquired resistance to P. carinii infection, and to characterize the antigenic determinants of P. carinii recognized by the protective immune response at the molecular level. Of the antigens recognized by the immune response to P. carinii, passive immunization studies that have targeted an abundant surface molecule termed glycoprotein A (gpA) provide the only concrete examples of a specific P. carinii antigen important in protection against infection. The immediate goal of the proposal will be to characterize the molecular structure of gpA so that it may he more effectively targeted for immune attack against P. carinii. Mouse models of P. carinii pneumonia (PCP) provide the only experimental system in which immunization affords complete protection against infection. Since only mouse-derived P. carinii will establish infection in the mouse, immunological analysis of the pathogenesis of PCP mandates the use of mouse P. carinii antigens. Therefore, the first aim of the proposal will be to clone and characterize the cDNA encoding mouse P. carinii gpA, in order to deduce its primary amino acid structure and to provide a source of recombinant antigen for immunological analyses. Passive immunoprophylaxis with either of two monoclonal antibodies (MAbs) specific for gpA results in significant reduction in vivo of P. carinii organisms bearing their respective epitopes.
The second aim of the proposal will be to identify peptides recognized by these MAbs through the screening of combinatorial peptide display libraries. The ability of candidate peptides to function as protective immunogens will be compared to the protection afforded by passive immunization with their respective MAb. The candidate peptides will also be used to characterize the immune response to native gpA. Completion of the two objectives of this proposal will yield important molecular reagents to be used in the study of immunity to P. carinii, and will help define the molecular basis for acquired resistance to infection against PCP.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL049610-06
Application #
2685404
Study Section
Special Emphasis Panel (ZRG5-ARRB (01))
Project Start
1992-08-01
Project End
2000-03-31
Budget Start
1998-04-01
Budget End
2000-03-31
Support Year
6
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Rochester
Department
Microbiology/Immun/Virology
Type
Schools of Dentistry
DUNS #
208469486
City
Rochester
State
NY
Country
United States
Zip Code
14627
Odrljin, T M; Haidaris, C G; Lerner, N B et al. (2001) Integrin alphavbeta3-mediated endocytosis of immobilized fibrinogen by A549 lung alveolar epithelial cells. Am J Respir Cell Mol Biol 24:12-21
Lee, L H; Gigliotti, F; Wright, T W et al. (2000) Molecular characterization of KEX1, a kexin-like protease in mouse Pneumocystis carinii. Gene 242:141-50
Haidaris, C G; Fisher, D J; Gigliotti, F et al. (1998) Antigenic properties of recombinant glycosylated and nonglycosylated Pneumocystis carinii glycoprotein A polypeptides expressed in baculovirus-infected insect cells. Mol Biotechnol 9:91-7
Haidaris, C G; Medzihradsky, O F; Gigliotti, F et al. (1998) Molecular characterization of mouse Pneumocystis carinii surface glycoprotein A. DNA Res 5:77-85
Gigliotti, F; Garvy, B A; Haidaris, C G et al. (1998) Recognition of Pneumocystis carinii antigens by local antibody-secreting cells following resolution of P. carinii pneumonia in mice. J Infect Dis 178:235-42
Guadiz, G; Haidaris, C G; Maine, G N et al. (1998) The carboxyl terminus of Pneumocystis carinii glycoprotein A encodes a functional glycosylphosphatidylinositol signal sequence. J Biol Chem 273:26202-9
Testa, S M; Haidaris, C G; Gigliotti, F et al. (1997) A Pneumocystis carinii group I intron ribozyme that does not require 2' OH groups on its 5' exon mimic for binding to the catalytic core. Biochemistry 36:15303-14
Gigliotti, F; McCool, T (1996) Glycoprotein A is the immunodominant antigen of Pneumocystis carinii in mice following immunization. Parasitol Res 82:90-1
Wright, T W; Bissoondial, T Y; Haidaris, C G et al. (1995) Isoform diversity and tandem duplication of the glycoprotein A gene in ferret Pneumocystis carinii. DNA Res 2:77-88
Simpson-Haidaris, P J; Wright, T W; Earnest, B J et al. (1995) Cloning and characterization of a lung-specific cDNA corresponding to the gamma chain of hepatic fibrinogen. Gene 167:273-8

Showing the most recent 10 out of 16 publications